Registration
BROWNSTEIN HYATT FARBER SCHRECK, LLP for AIPHARMA GLOBAL HOLDINGS LIMITED
Income
—
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Issues related to the pharmaceutical supply chain
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURA JOHNSON BOLLIER New | Legislative intern - Senate HELP Committee |
| DAVID PHILLIP COHEN New | Prof. Staff-House Comm on Banking & Fin Svcs |
| EMILY FELDER New | Director of the Office of Legislation, CMS; Counsel, House Energy and Commerce Committee; Counsel, Senate Committee on Homeland Security and Government Affairs; Counsel, House Oversight and Government Reform Committee |
| MARK L. PRYOR New | United States Senator |
| ADAM STEINMETZ New | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| JULIA HELIN | Sweden | Sweden | 25.0% | — |
| OMAR ARRAB | United Arab Emirates | United Arab Emirates | 55.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.